Atlas Trials

Metastatic Castrate Resistant Prostate Cancer

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Castrate Resistant Prostate Cancer

RecordFirmDate
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer (NCT04038502)VA Office of Research and Development2019-10-01
MGC018 With or Without MGA012 in Advanced Solid Tumors (NCT03729596)MacroGenics2018-11-21
Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer (NCT03737370)Tufts Medical Center2018-01-30
Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients (NCT02987829)Tracon Pharmaceuticals Inc.2017-05-23
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP) (NCT03236688)Exosome Diagnostics, Inc.2016-02-01
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer (NCT02607228)Gilead Sciences2015-12-08
Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer (NCT03761225)AB Science2014-09-01
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts (NCT02266745)Promontory Therapeutics Inc.2014-07-01
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer (NCT02008058)UNC Lineberger Comprehensive Cancer Center2014-01-23
Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC) (NCT01818986)University of Texas Southwestern Medical Center2013-07-10
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy (NCT01732549)Ipsen2013-01-01
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone (NCT01681433)Costantine Albany2012-12-01
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib (NCT01540526)University of Wisconsin, Madison2012-03-01
A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) (NCT01090765)National Cancer Institute (NCI)2010-02-23

Track Metastatic Castrate Resistant Prostate Cancer automatically

Every clearance here is in the API, with alerts when new ones post.